The biopharmaceutical industry is developing a new approach to controlling variability in raw materials.
USP evaluates raw materials used in the chemical synthesis of peptides.
A review of the past year's trends in biopharmaceutical approvals shows an above average approval rate.
How badly is Brazil's pharmaceutical market suffering from the global instability of emerging markets?
The presence of minute amounts of chelators can help minimize the degradation of monoclonal antibodies.
The approval and acceptance of monoclonal antibody biosimilars is necessary if the biosimilars market is to experience real growth.
Research uncovers trends and factors affecting the pre-packed disposable chromatography columns market for downstream bioprocessing.
USP evaluates quality attributes for synthetic peptides.
Researchers are using current understanding of the lyophilization process to predict performance on many levels during both process development and manufacturing.